Company profile
Elanco Animal Health Incorporated
NYSE: ELAN · Healthcare · Drug Manufacturers - Specialty & Generic
#64 of 1,418 Healthcare companies by revenue50th-percentile growth
EA Score
66BFH 73DQ 64GM 42SS 76
v0.1 · 65/100 weight · provisional
↑ market scale, workforce scale · ↓ growth stability, listing tenure
Methodology →Revenue TTM
$4.9B
Rev growth YoY (TTM)
+10.5%
Net income (FY)
-$232.0M
Employees
9,900
as of 2026-08-05
Market cap
$12.8B
as of 2026-08-05
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$4.7B$4.7B2025
Net income-$232.0M-$232.0M2025
Total assets$13.4B$13.4B2025
Liabilities$6.8B$6.8B2025
Equity$6.5B$6.5B2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY22
FY22
FY22
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Farm Animal33%
Pet Health32%
Cattle16%
Poultry12%
Swine5%
Contract Manufacturing1%
By geography
Non-US53%
UNITED STATES47%
The read
What is Elanco Animal Health Incorporated’s revenue?
Elanco Animal Health Incorporated booked $4.7B in FY2025 revenue, growing 6.2% year over year — about the middle of the pack among Healthcare companies we track, at a -4.9% net margin.
Peers · Healthcare
Incyte Corporation90ABausch + Lomb Corporation67BThe Ensign Group, Inc.80B+DexCom, Inc.87AIllumina, Inc.84B+IDEXX Laboratories, Inc.88AKey facts
CEOJeffrey N. Simmons
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersGreenfield, IN
ExchangeNYSE: ELAN
Employees9,900
IPO date2018-09-20
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.